OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CircHIPK2 Contributes to DDP Resistance and Malignant Behaviors of DDP-Resistant Ovarian Cancer Cells Both in vitro and in vivo Through circHIPK2/miR-338-3p/CHTOP ceRNA Pathway
Yang Cao, Xin Xie, Mingzhu Li, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 3151-3165
Open Access | Times Cited: 28
Yang Cao, Xin Xie, Mingzhu Li, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 3151-3165
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
Xuehao Zhou, Xiang Ao, Zhaojun Jia, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 79
The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review
Sajad Najafi
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 2211-2234
Closed Access | Times Cited: 53
Sajad Najafi
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 2211-2234
Closed Access | Times Cited: 53
Exosome-transmitted circ IFNGR2 Modulates Ovarian Cancer Metastasis via miR-378/ST5 Axis
Xiaoping Chen, Xinping Ren, E Jiaoting, et al.
Molecular and Cellular Biology (2023) Vol. 43, Iss. 1, pp. 22-42
Open Access | Times Cited: 19
Xiaoping Chen, Xinping Ren, E Jiaoting, et al.
Molecular and Cellular Biology (2023) Vol. 43, Iss. 1, pp. 22-42
Open Access | Times Cited: 19
HIPK2 in cancer biology and therapy: Recent findings and future perspectives
A. Conte, Valeria Valente, Simona Paladino, et al.
Cellular Signalling (2022) Vol. 101, pp. 110491-110491
Open Access | Times Cited: 23
A. Conte, Valeria Valente, Simona Paladino, et al.
Cellular Signalling (2022) Vol. 101, pp. 110491-110491
Open Access | Times Cited: 23
CircHIPK2 Contributes Cell Growth in Intestinal Epithelial of Colitis and Colorectal Cancer through Promoting TAZ Translation
Xixi Zeng, Jielin Tang, Qian Zhang, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Xixi Zeng, Jielin Tang, Qian Zhang, et al.
Advanced Science (2024)
Open Access | Times Cited: 5
Mechanism of microRNA-152-3p-Mediated Regulation of Autophagy and Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells
Di Wu, Yang Zhang, Luna Zhang, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 179-197
Open Access
Di Wu, Yang Zhang, Luna Zhang, et al.
OncoTargets and Therapy (2025) Vol. Volume 18, pp. 179-197
Open Access
Hsa_circ_0001756 drives gastric cancer glycolysis by increasing the expression and stability of PGK1 mRNA
Long Qian, Luman Wang, Hao Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Long Qian, Luman Wang, Hao Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Biology and pharmacological inhibition of homeodomain-interacting protein kinases
Adam Štefek, Kamil Paruch
Frontiers in Chemical Biology (2025) Vol. 4
Open Access
Adam Štefek, Kamil Paruch
Frontiers in Chemical Biology (2025) Vol. 4
Open Access
Dysregulated Circular RNA and Long non-coding RNA-Mediated Regulatory Competing Endogenous RNA Networks (ceRNETs) in Ovarian and Cervical Cancers: A Non-coding RNA-Mediated Mechanism of Chemotherapeutic Resistance with New Emerging Clinical Capacities
Danial Amiri Manjili, Fatemeh Naghdi Babaei, Tayebeh Younesirad, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110389-110389
Closed Access
Danial Amiri Manjili, Fatemeh Naghdi Babaei, Tayebeh Younesirad, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110389-110389
Closed Access
The Function of Circular RNAs in Regulating Wnt/β-Catenin Signaling: An Innovative Therapeutic Strategy for breast and gynecological Cancers
Samaneh Kahkesh, Neda Hedayati, Payman Rahimzadeh, et al.
Pathology - Research and Practice (2025), pp. 155944-155944
Closed Access
Samaneh Kahkesh, Neda Hedayati, Payman Rahimzadeh, et al.
Pathology - Research and Practice (2025), pp. 155944-155944
Closed Access
Circular RNA lysophosphatidic acid receptor 3 (circ-LPAR3) enhances the cisplatin resistance of ovarian cancer
Xuemei Liu, Zhiping Yin, Yanjun Wu, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 3739-3750
Open Access | Times Cited: 18
Xuemei Liu, Zhiping Yin, Yanjun Wu, et al.
Bioengineered (2022) Vol. 13, Iss. 2, pp. 3739-3750
Open Access | Times Cited: 18
Emerging role of circular RNAs in the pathogenesis of ovarian cancer
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 15
The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer
Mingming Ren, Xiang Song, Jieting Niu, et al.
Experimental Cell Research (2022) Vol. 419, Iss. 2, pp. 113276-113276
Closed Access | Times Cited: 15
Mingming Ren, Xiang Song, Jieting Niu, et al.
Experimental Cell Research (2022) Vol. 419, Iss. 2, pp. 113276-113276
Closed Access | Times Cited: 15
Circular RNAs in gynecologic cancers: mechanisms and implications for chemotherapy resistance
Meiying Qin, Chunmei Zhang, Li Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
Meiying Qin, Chunmei Zhang, Li Yang
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 8
CircRNA_0008194 functions as a ceRNA to promote invasion of hepatocellular carcinoma via inhibiting miR‐190a/AHNAK signaling pathway
Wei Liu, Ying Pan, Hengbo Zhu, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 4
Open Access | Times Cited: 12
Wei Liu, Ying Pan, Hengbo Zhu, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 4
Open Access | Times Cited: 12
HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
Alessia Garufi, Valerio D’Orazi, Giuseppa Pistritto, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1566-1566
Open Access | Times Cited: 6
Alessia Garufi, Valerio D’Orazi, Giuseppa Pistritto, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1566-1566
Open Access | Times Cited: 6
Advances in the Study of CircRNAs in Tumor Drug Resistance
Song Wang, Long Qian, Tingting Cao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Song Wang, Long Qian, Tingting Cao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Circular RNAs in Epithelial Ovarian Cancer: From Biomarkers to Therapeutic Targets
Yumin Qiu, Yan Chen, Oluwatobi Agbede, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5711-5711
Open Access | Times Cited: 9
Yumin Qiu, Yan Chen, Oluwatobi Agbede, et al.
Cancers (2022) Vol. 14, Iss. 22, pp. 5711-5711
Open Access | Times Cited: 9
Circ_0000140 Alters miR-527/SLC7A11-Mediated Ferroptosis to Influence Oral Squamous Cell Carcinoma Cell Resistance to DDP
Yu Ma, Jinbo Gao, Hongning Guo
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 1079-1089
Open Access | Times Cited: 5
Yu Ma, Jinbo Gao, Hongning Guo
Pharmacogenomics and Personalized Medicine (2023) Vol. Volume 16, pp. 1079-1089
Open Access | Times Cited: 5
ceRNA networks in gynecological cancers progression and resistance
Shuqin Wu, Baoshan Zhong, Yuxin Yang, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 9, pp. 920-930
Closed Access | Times Cited: 3
Shuqin Wu, Baoshan Zhong, Yuxin Yang, et al.
Journal of drug targeting (2023) Vol. 31, Iss. 9, pp. 920-930
Closed Access | Times Cited: 3
Recent advances in the contribution of circRNAs to cisplatin chemotherapy resistance in cancers
Chao Mu, Xiaolu Wang, Ying Ruan, et al.
Neoplasma (2021) Vol. 68, Iss. 06, pp. 1119-1131
Open Access | Times Cited: 6
Chao Mu, Xiaolu Wang, Ying Ruan, et al.
Neoplasma (2021) Vol. 68, Iss. 06, pp. 1119-1131
Open Access | Times Cited: 6
Circ_0001756, a novel biomarker, promotes breast cancer progression via miR-584-5p/TRAF6 signaling axis
Junying Wu, Xixi Wu, Liyan Shi, et al.
Research Square (Research Square) (2024)
Open Access
Junying Wu, Xixi Wu, Liyan Shi, et al.
Research Square (Research Square) (2024)
Open Access
Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in PreclinicalIn VivoModels: Identification of Targets and New Modalities for Therapeutic Intervention
Ulrich H. Weidle, Fabian Birzele
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 3, pp. 213-237
Open Access
Ulrich H. Weidle, Fabian Birzele
Cancer Genomics & Proteomics (2024) Vol. 21, Iss. 3, pp. 213-237
Open Access
Mechanism of microRNA-152-3p-mediated regulation of autophagy and sensitivity in paclitaxel-resistant ovarian cancer cells
Di Wu, Yang Zhang, Luna Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Di Wu, Yang Zhang, Luna Zhang, et al.
Research Square (Research Square) (2024)
Open Access
Hsa‐miR‐503‐5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells
Han Jian-wei, Yan Wang
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 4, pp. 749-762
Closed Access | Times Cited: 1
Han Jian-wei, Yan Wang
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 4, pp. 749-762
Closed Access | Times Cited: 1
